{
  "title": "Support for Africa’s Vaccine Production is Good for the World",
  "publication": "IMF Blog, January 12, 2022",
  "sourceUrl": "https://www.imf.org/en/blogs/articles/2022/01/12/blog011322-support-for-africas-vaccine-production-is-good-for-the-world",
  "canonical": "https://www.imf.org/en/blogs/articles/2022/01/12/blog011322-support-for-africas-vaccine-production-is-good-for-the-world",
  "overlayPath": "/en/blogs/articles/2022/01/12/blog011322-support-for-africas-vaccine-production-is-good-for-the-world/index.md",
  "summary": "Robust and reliable vaccine capacity in Africa is a global public good, deserving of global support.",
  "sections": [
    {
      "heading": "Overview",
      "content": "- Author: Kristalina Georgieva\n- Date: January 12, 2022\n- Core message: Robust and reliable vaccine capacity in Africa is a global public good and deserves global support.\n- Context: Pandemic entering third year; Omicron variant emergence underscores global implications of Africa’s vaccine access."
    },
    {
      "heading": "Immediate challenges and meeting today’s needs",
      "content": "- Africa’s overall COVID vaccination rate on the continent is still below 10 percent.\n- Africa remains reliant on COVID‑19 vaccine imports and donations.\n- Immediate priorities:\n  - Guarantee predictability in vaccine deliveries — including through COVAX and the African Vaccine Acquisition Trust (AVAT).\n  - Fund health systems to vaccinate populations swiftly as new supplies arrive, including outreach to reduce misinformation and vaccine hesitancy.\n  - Ensure access to tests, treatments, and protective equipment.\n- IMF staff vaccination targets and progress:\n  - Plan: vaccinate 40 percent of the population of all countries by end-2021 and 70 percent by mid-2022.\n  - Outcome: Only seven countries in Africa reached the 40 percent target in 2021.\n  - Observation: For many countries, the 70 percent target seems increasingly ambitious.\n- Financing gap:\n  - Closing the $23 billion financing gap of the Access to COVID‑19 Tools (ACT) Accelerator is recommended as a welcome first step; a sizable portion of this effort is directed toward Africa.\n- Emphasis: International support is framed as investment in a global public good — “no one is safe until everyone is safe.”"
    },
    {
      "heading": "Building resilience for the future",
      "content": "- Long-term objective: Scale up local manufacturing capacity and strengthen regional supply chains so resilience does not depend on repeated generosity.\n- Challenges of relying on imports/donations:\n  - Health authorities often must accept doses at short notice, often with limited shelf lives, complicating delivery logistics for already-stretched health systems.\n- Vaccine manufacturing requirements:\n  - Specialized equipment, inputs, storage facilities, and skilled labor."
    },
    {
      "heading": "African capacity and initiatives",
      "content": "- Institut Pasteur, Dakar:\n  - Recognized as a world-class leader in infectious disease response and training.\n  - With financial assistance from the United States, European Union, and international foundations — and use of some of Senegal’s recent SDR allocation — construction of a new manufacturing facility is underway.\n  - When complete, it will be one of the first start-to-finish factories on the continent.\n- Regional scientific contributions:\n  - Africa discovered and sequenced the Omicron variant.\n  - There are 12 production facilities, either in operation or in the pipeline, across six African countries — Algeria, Egypt, Morocco, Rwanda, Senegal, and South Africa — expected to produce a wide range of COVID‑19 vaccines."
    },
    {
      "heading": "Policy recommendations and international actions urged",
      "content": "- Step up cross-border collaboration in science.\n- Incentivize technological transfers to diversify the production of vaccines and other life-saving medical tools.\n- Provide predictable financing and delivery mechanisms (e.g., support for COVAX and AVAT).\n- Close the $23 billion ACT Accelerator financing gap to support Africa-targeted efforts.\n- Support “last mile” delivery capacity in countries to complement vaccine supply."
    },
    {
      "heading": "Key statements and quotations",
      "content": "- “Africa vaccinating Africa is necessary—and it is achievable.”\n- “To be clear, this international support is not charity. This is a global public good!”\n- Louis Pasteur quotation cited: “Science knows no country, because knowledge belongs to humanity, and is the torch which will illuminate the world.”\n\nSource: IMF blog post “Support for Africa’s Vaccine Production is Good for the World” by Kristalina Georgieva, January 12, 2022.\n\n---\n\n\n References\n\n- https://www.imf.org/wp-content/uploads/2022/01/FINAL-AFR-Vaccine-Production-Blog-Chart-1.jpg\n- plan to end the pandemic\n- https://www.imf.org/wp-content/uploads/2022/01/Vaccine-Production-Blog-Chart-2.jpeg\n\nSource: https://www.imf.org/en/blogs/articles/2022/01/12/blog011322-support-for-africas-vaccine-production-is-good-for-the-world"
    }
  ],
  "bullets": [
    "[Markdown version](/en/blogs/articles/2022/01/12/blog011322-support-for-africas-vaccine-production-is-good-for-the-world/index.md)",
    "[Structured JSON version](/en/blogs/articles/2022/01/12/blog011322-support-for-africas-vaccine-production-is-good-for-the-world/index.json)",
    "[Bundle manifest](/en/blogs/articles/2022/01/12/blog011322-support-for-africas-vaccine-production-is-good-for-the-world/bundle-manifest.json)",
    "Authors: Kristalina Georgieva",
    "Published: January 12, 2022",
    "Author: Kristalina Georgieva",
    "Date: January 12, 2022",
    "Core message: Robust and reliable vaccine capacity in Africa is a global public good and deserves global support.",
    "Context: Pandemic entering third year; Omicron variant emergence underscores global implications of Africa’s vaccine access.",
    "Africa’s overall COVID vaccination rate on the continent is still below 10 percent.",
    "Africa remains reliant on COVID‑19 vaccine imports and donations.",
    "Immediate priorities:",
    "IMF staff vaccination targets and progress:",
    "Financing gap:",
    "Emphasis: International support is framed as investment in a global public good — “no one is safe until everyone is safe.”",
    "Long-term objective: Scale up local manufacturing capacity and strengthen regional supply chains so resilience does not depend on repeated generosity.",
    "Challenges of relying on imports/donations:",
    "Vaccine manufacturing requirements:",
    "Institut Pasteur, Dakar:",
    "Regional scientific contributions:",
    "Step up cross-border collaboration in science.",
    "Incentivize technological transfers to diversify the production of vaccines and other life-saving medical tools.",
    "Provide predictable financing and delivery mechanisms (e.g., support for COVAX and AVAT).",
    "Close the $23 billion ACT Accelerator financing gap to support Africa-targeted efforts.",
    "Support “last mile” delivery capacity in countries to complement vaccine supply.",
    "“Africa vaccinating Africa is necessary—and it is achievable.”",
    "“To be clear, this international support is not charity. This is a global public good!”",
    "Louis Pasteur quotation cited: “Science knows no country, because knowledge belongs to humanity, and is the torch which will illuminate the world.”",
    "[https://www.imf.org/wp-content/uploads/2022/01/FINAL-AFR-Vaccine-Production-Blog-Chart-1.jpg](https://www.imf.org/wp-content/uploads/2022/01/FINAL-AFR-Vaccine-Production-Blog-Chart-1.jpg)",
    "[plan to end the pandemic](https://www.imf.org/en/Publications/Staff-Discussion-Notes/Issues/2021/05/19/A-Proposal-to-End-the-COVID-19-Pandemic-460263)",
    "[https://www.imf.org/wp-content/uploads/2022/01/Vaccine-Production-Blog-Chart-2.jpeg](https://www.imf.org/wp-content/uploads/2022/01/Vaccine-Production-Blog-Chart-2.jpeg)"
  ],
  "alternates": {
    "markdown": "/en/blogs/articles/2022/01/12/blog011322-support-for-africas-vaccine-production-is-good-for-the-world/index.md",
    "json": "/en/blogs/articles/2022/01/12/blog011322-support-for-africas-vaccine-production-is-good-for-the-world/index.json",
    "bundleManifest": "/en/blogs/articles/2022/01/12/blog011322-support-for-africas-vaccine-production-is-good-for-the-world/bundle-manifest.json"
  },
  "generatedAtUtc": "2026-08-27T02:04:34.070Z"
}
